VIDEO: Physicians should be more aware of chronic liver disease treatment guidelines
Click Here to Manage Email Alerts
LAS VEGAS – In this video exclusive, Nancy S. Reau, MD, FAASLD, AGAF, discussed the Liver Health Annual Trends Report, which was launched during a panel discussion hosted by Salix Pharmaceuticals at the ACG Annual Scientific Meeting.
The report surveyed 100 physicians who dealt with the management of chronic liver disease.
Reau, the Richard B. Capps Chair of Hepatology at Rush University in Chicago, said the face of liver disease is changing. She noted 42% to 43% of physicians said they felt that their most common diagnosis was nonalcoholic fatty liver disease or nonalcoholic steatohepatitis. This was different from previous reports in which the most common diagnosis was alcohol use disorder or viral hepatitis. The survey now includes mostly a fatty liver population.
“Providers were struck by the fact that liver disease was presenting at a most serious time point and a little more aggressive,” Reau said.
She noted many providers reported a lack of awareness for guidelines available for treatment of chronic liver disease.
“More importantly, about one-third of physicians that recognize the guidelines did exist said that they didn’t always use the guidelines,” she said. “That’s important when we are looking at what the guidelines are for. This either suggests that the tool wasn’t useful for the clinician or that the clinician was aware of the recommendations but still felt that for their patients’ management they needed to do something differently, or they didn’t feel it was a very easy to use resource.”
Collapse
Liver Health Annual Trends Report. https://cat02.cc-tools.online/liver-health-annual-trends-report-first-edition/page/1. Published Oct. 25, 2021. Accessed Oct. 25, 2021.
Click Here to Manage Email Alerts